Epstein Secrets

09/18/2018 16:38 From: INIMINIM Woodson C. Merrell M Uebfax Page: 1/11 FAX COVER SHEET To: Jeffrey Epstein / Lesley From: Lisa Company: Company: Woodson Merrell MD PLLC Phone: Pages w/cover: 11 Fax: Date: 9/18/2018 Subject: 9-14-18 LABCORP (

/2010 16:30 From: 3477565616 Woodson C. Merrell M Wehfax Page: 2/11 LabCorp Patient Report Specimen ID: 257-480 2371-0 Control ID: FSB31: 43092 EPSTEIN, JEFFREY 9E 71STST NEW YORK W 10021 Acct 31143092 Woodson Merrell 44 E67th St New York NY 10065 Phone Patient Details Specimen Details Phy

30 From: 3477565616 Woodson C. Merrell M Wehfax Page: 2/11 LabCorp Patient Report Specimen ID: 257-480 2371-0 Control ID: FSB31: 43092 EPSTEIN, JEFFREY 9E 71STST NEW YORK W 10021 Acct 31143092 Woodson Merrell 44 E67th St New York NY 10065 Phone Patient Details Specimen Details Physician De

) Glucose 128 High mg/dL 65 - 99 01 Sample is lipamic. This may cause spurious AST, ALT, and GIBC (if ordered). Clinical increases in TBili, DBili, correlation indicated. Rte: 68 Fasting: No Specimen received hemolyzed. Clinical correlation indicated. Date Issued: 09/1&181053 ET PRELIMINAR

09/21/2018 10:18 From: Woodson C. Merrel l M Uebfax Page: 1/13 FAX COVER SHEET fo: Jeffrey Epstein / Company: Fax: Date: 9/21/2018 Subject: 9-14-18 LABCORP Lab Results Jeff From: Lisa Company: Woodson Merrell MD PLLC Phone: Pages w/cove

99800 09/21/2018 10:18 From: Woodson C. Merrell M Uebfax Page: 2/13 LabCorp Patient Report ,!me:, i:1 ",r-lbrU-2371-0 Convo! ID: F3 [143092 EPSTEIN, JEFFREY IS: ST NEW YORK NY 10021 Acct 31143092 Woodson Merrell 44E6AhS( New York NY 10065 Phone: Patient Details Specimen Details Physici

9/21/2018 10:18 From: Woodson C. Merrell M Uebfax Page: 2/13 LabCorp Patient Report ,!me:, i:1 ",r-lbrU-2371-0 Convo! ID: F3 [143092 EPSTEIN, JEFFREY IS: ST NEW YORK NY 10021 Acct 31143092 Woodson Merrell 44E6AhS( New York NY 10065 Phone: Patient Details Specimen Details Physician Detail

uL 0.0 - 0.1 01 Comp. Metabolic Panel (14) Glucose 128 High mg/dL 65 - 99 01 Sample is lipemic. This may cause spurious increases in TBili, DBili, AST, ALT, and =X (if ordered). Clinical correlation indicated. Specimen received hemolyzed. Clinical correlation indicated. Datehmed:09/20/160032

09,18,2016 16:30 Froe: lioodson C. Merrell M Webfax Page: 2,11 3LabCorp Patient Report Specimen iD: 21, 7 -0 Control ID:r5 : 43)92 EPSTEIN, JEFFREY 9 E 7ISTST NEW YORK NY 10:;' Patient Details 008:01/20/1953 Age(y/m/d): 065437/25 Ginder: M 55ft Patient IM Acct F.31143092 Phon.:

09,18,2016 16:30 Froe: lioodson C. Merrell M Webfax Page: 2,11 3LabCorp Patient Report Specimen iD: 21, 7 -0 Control ID:r5 : 43)92 EPSTEIN, JEFFREY 9 E 7ISTST NEW YORK NY 10:;' Patient Details 008:01/20/1953 Age(y/m/d): 065437/25 Ginder: M 55ft Patient IM Acct F.31143092 Phon.: Rte: 68

1023/1.11. 0.0 - 0.1 Coap. Netabolic Panel (14) Glucose 128 High ng/dL 65 - 99 Sample is lipeaio. This may causa spurious increases in TBili, DBili, AST, ALT, and UIBC (if ordared). Clinical correlation indicated. Specimen received beaolyxed. Clinical corralation indicated. 01 01 01 01 01

1,2918 18:18 From: Uoodson C. Merrell M Uebfax Page: 2/13 eLabcorp Specimen ID: 151-480-2371-0 Control m F5831143092 Patient Report EPSTEIN,JEFFRET 9 E 71ST ST NEW YORK NY 10021 Patientnails P08:01/20/1953 Aselykerd):063107/2.5 Gender: M SSN: Patient XX Acct 31143092 Phone ate: 68 Wo

89,21,2918 18:18 From: Uoodson C. Merrell M Uebfax Page: 2/13 eLabcorp Specimen ID: 151-480-2371-0 Control m F5831143092 Patient Report EPSTEIN,JEFFRET 9 E 71ST ST NEW YORK NY 10021 Patientnails P08:01/20/1953 Aselykerd):063107/2.5 Gender: M SSN: Patient XX Acct 31143092 Phone ate

ucose, 128 Nigh mg/d3/ 65 - 99 01 Sample is lipemic. This may cause AST, ALT, and 13IBC (if ordered). spurious Clinical increases in TBili, DBili, correlation indicated. Physician Details OrderMg: W MERRELL Mewing: D: MERRELL 14M: 1023153509 Fatting: No Specimen received hemolysed. Cli

89/18/2818 16:38 From: Uoodson C. Merrell M Uebfax Page: 3/11 ;11-abeforP Patient Report Pmteat EPSTEJK JEFFREY DOB- V/20,1953 PatOm ID: antyoUDF5531'43092 Specimen Ife 257480-23? 1-0 Date cotiected: 09;14'201E • 255 Lock, TESTS RESULT FLAG UNIT$ REFER

n/1.73 >59 mL/min/1.73 >59 10 - 24 mmol/L 134 - 144 01 4.2 mmol/L 3.5 - 5.2 Sample is lipemic. This may cause spurious increases in TBili, DBili, AST, ALT, and UIBC (if ordered). Clinical correlation indicated. Specimen received hemolyzed. Clinical correlation indicated. al 01 Chloride 1